Period of time： 2014年11期
Publisher： Informa Healthcare
Founded in： 2006
Total resources： 77
ISSN： 1746-0441
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Drug Discovery,volume 2,issue 11
Menu
Access to resources
Recommend
The cost of pharmaceutical innovation to patients
By Keyhani Salomeh,Ross Joseph S in (2007)
Expert Opinion on Drug Discovery,volume 2,issue 11 , Vol. 2, Iss. 11, 2007-11 , pp.An update on mouse brain tumor models in cancer drug discovery
By Hambardzumyan Dolores,Lyustikman Yelena,Holland Eric C in (2007)
Expert Opinion on Drug Discovery,volume 2,issue 11 , Vol. 2, Iss. 11, 2007-11 , pp.By Müller-Hartmann Herbert,Faust Nicole,Kazinski Michael,Kretzschmar Titus in (2007)
Expert Opinion on Drug Discovery,volume 2,issue 11 , Vol. 2, Iss. 11, 2007-11 , pp.An update on using protein microarrays in drug discovery
By Kumble Krishnanand D in (2007)
Expert Opinion on Drug Discovery,volume 2,issue 11 , Vol. 2, Iss. 11, 2007-11 , pp.Widespread functional and molecular imaging in drug development
Expert Opinion on Drug Discovery,volume 2,issue 11 , Vol. 2, Iss. 11, 2007-11 , pp.Improving chemical synthesis using flow reactors
By Wiles Charlotte,Watts Paul in (2007)
Expert Opinion on Drug Discovery,volume 2,issue 11 , Vol. 2, Iss. 11, 2007-11 , pp.Nature's bounty – drug discovery from the sea
By Bowling John J,Kochanowska Anna J,Kasanah Noer,Hamann Mark T in (2007)
Expert Opinion on Drug Discovery,volume 2,issue 11 , Vol. 2, Iss. 11, 2007-11 , pp.Use of daptomycin for treatment of
By Eisenstein Barry I in (2007)
Expert Opinion on Drug Discovery,volume 2,issue 11 , Vol. 2, Iss. 11, 2007-11 , pp.Levetiracetam: the first SV2A ligand for the treatment of epilepsy
By Klitgaard Henrik,Verdru Peter in (2007)
Expert Opinion on Drug Discovery,volume 2,issue 11 , Vol. 2, Iss. 11, 2007-11 , pp.